X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Strides Arcolab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA STRIDES SHASUN LTD SHASUN PHARMA/
STRIDES SHASUN LTD
 
P/E (TTM) x 123.9 32.3 383.0% View Chart
P/BV x 8.5 0.9 987.2% View Chart
Dividend Yield % 0.2 1.1 20.4%  

Financials

 SHASUN PHARMA   STRIDES SHASUN LTD
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
STRIDES SHASUN LTD
Mar-17
SHASUN PHARMA/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs941,275 7.4%   
Low Rs46918 5.0%   
Sales per share (Unadj.) Rs214.2389.6 55.0%  
Earnings per share (Unadj.) Rs5.328.0 19.1%  
Cash flow per share (Unadj.) Rs15.848.9 32.4%  
Dividends per share (Unadj.) Rs1.004.50 22.2%  
Dividend yield (eoy) %1.40.4 348.5%  
Book value per share (Unadj.) Rs53.3303.1 17.6%  
Shares outstanding (eoy) m56.6289.42 63.3%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.32.8 11.6%   
Avg P/E ratio x13.139.2 33.4%  
P/CF ratio (eoy) x4.422.4 19.7%  
Price / Book Value ratio x1.33.6 36.2%  
Dividend payout %18.716.1 116.5%   
Avg Mkt Cap Rs m3,95898,036 4.0%   
No. of employees `000NA5.8 0.0%   
Total wages/salary Rs m2,1645,881 36.8%   
Avg. sales/employee Rs ThNM6,005.9-  
Avg. wages/employee Rs ThNM1,014.0-  
Avg. net profit/employee Rs ThNM431.2-  
INCOME DATA
Net Sales Rs m12,12734,834 34.8%  
Other income Rs m2291,686 13.6%   
Total revenues Rs m12,35636,520 33.8%   
Gross profit Rs m1,0096,428 15.7%  
Depreciation Rs m5941,872 31.7%   
Interest Rs m4152,269 18.3%   
Profit before tax Rs m2303,973 5.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m04 -8.3%   
Extraordinary Inc (Exp) Rs m0-1,006 0.0%   
Tax Rs m-73470 -15.5%   
Profit after tax Rs m3022,501 12.1%  
Gross profit margin %8.318.5 45.1%  
Effective tax rate %-31.711.8 -267.6%   
Net profit margin %2.57.2 34.7%  
BALANCE SHEET DATA
Current assets Rs m6,88438,165 18.0%   
Current liabilities Rs m8,45630,402 27.8%   
Net working cap to sales %-13.022.3 -58.2%  
Current ratio x0.81.3 64.9%  
Inventory Days Days6277 79.7%  
Debtors Days Days108104 102.9%  
Net fixed assets Rs m4,97037,639 13.2%   
Share capital Rs m113894 12.7%   
"Free" reserves Rs m2,87526,210 11.0%   
Net worth Rs m3,02027,105 11.1%   
Long term debt Rs m1,81716,377 11.1%   
Total assets Rs m13,34781,168 16.4%  
Interest coverage x1.62.8 56.5%   
Debt to equity ratio x0.60.6 99.6%  
Sales to assets ratio x0.90.4 211.7%   
Return on assets %5.45.9 91.4%  
Return on equity %10.09.2 108.4%  
Return on capital %13.312.1 110.5%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,84313,465 43.4%   
Fx outflow Rs m2,1734,076 53.3%   
Net fx Rs m3,6699,389 39.1%   
CASH FLOW
From Operations Rs m3982,881 13.8%  
From Investments Rs m-1,635-7,051 23.2%  
From Financial Activity Rs m1,3093,382 38.7%  
Net Cashflow Rs m71-788 -9.0%  

Share Holding

Indian Promoters % 39.2 27.7 141.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 37.8 9.5%  
FIIs % 17.6 8.6 204.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 25.9 152.9%  
Shareholders   20,750 56,241 36.9%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   FULFORD INDIA  VENUS REMEDIES  IPCA LABS  WOCKHARDT LTD.  SUVEN LIFE  

Compare SHASUN PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 219 Points Lower; Energy and Auto Stocks Witness Selling(Closing)

After witnessing volatile trades during the day, Indian share markets ended their session on a negative note. Losses were largely seen in the oil & gas sector, auto sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - AUROBINDO PHARMA COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS